Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin vs Ixabepilone Neuropathy Study in Advanced Breast Cancer
NCT00879086Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2009
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eribulin in breast cancer, sponsored by Eisai Co., Ltd.. Started Mar 2009; status: completed.
02
Drugs
eribulin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00879086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00879086.